Enovix Corporation (ENVX) Tops Q4 EPS by 3c, provides guidance

Enovix Corporation (NASDAQ: ENVX) reported Q4 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $11.26 million versus the consensus estimate of $9.98 million.

GUIDANCE:

Enovix Corporation sees Q1 2026 EPS of ($0.14)-($0.18), versus the consensus of ($0.15). Enovix Corporation sees Q1 2026 revenue of $6.5-7.5 million, versus the consensus of $9.721 million.

For earnings history and earnings-related data on Enovix Corporation (ENVX) click here.

You May Also Be Interested In

• Sanuwave Q2 2026 revenue tops revised guidance range
• Gyre Therapeutics (GYRE) files for 31.03M share offering by selling stockholders
• Lode Gold plans $7M private placement with Coast Capital follow-on